Early cleavage does not predict treatment outcome following the use of GnRH antagonists in women older than 35

Fertility and Sterility

Volumn 88, Issue 6, 2007, Pages 1573-1578

  Yang, Wen Jui ^a   Hwu, Yuh Ming ^a,b   Lee, Robert Kuo kuang ^a   Li, Sheng Hsiang ^a   Lin, Shyr Yeu ^a   Fleming, Steven ^c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Early cleavage; GnRH agonist; GnRH antagonist; long protocol

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; PROGEFFIK; PROGESTERONE DERIVATIVE; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG USE; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; NIDATION; OOCYTE CLEAVAGE; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ZYGOTE;

ADULT; AGE FACTORS; CELL SURVIVAL; CLEAVAGE STAGE, OVUM; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; MENOTROPINS; PREGNANCY; PREGNANCY RATE; PROGNOSIS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 36749051280     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.01.052     Document Type: Article

References (34)

1. Borini A., Lagalla C., Cattoli M., Sereni E., Sciajno R., Flamigni C., et al. Predictive factors for embryo implantation potential. Repro Biomed Online 10 (2005) 653-668
2. Shoukir Y., Campana A., Farley T., and Sakkas D. Early cleavage of in vitro fertilized human embryos to the 2-cell stage: a novel indicator of embryo quality and viability. Hum Reprod 12 (1997) 1531-1536
3. Sakkas D., Shoukir Y., Chardonnens D., Bianchi P.G., and Campana A. Early cleavage of human embryos to the two-cell stage after intracytoplasmic sperm injection as an indicator of embryo viability. Hum Reprod 13 (1998) 182-187
4. Lundin K., Bergh C., and Hardarson T. Early embryo cleavage is a strong indicator of embryo quality in human IVF. Hum Reprod 16 (2001) 2652-2657
5. Bos-Mikich A., Mattos A.L., and Ferrari A.N. Early cleavage of human embryos: an effective method for predicting successful IVF/ICSI outcome. Hum Reprod 16 (2001) 2658-2661
6. Fenwick J., Platteau P., Murdoch A.P., and Herbert M. Time from insemination to first cleavage predicts developmental competence of human preimplantation embryos in vitro. Hum Reprod 17 (2002) 407-412
7. Salumets A., Hyden-Granskog C., Makinen S., Suikkari A.M., Tiitinen A., and Tuuri T. Early cleavage predicts the viability of human embryos in elective single embryo transfer procedures. Hum Reprod 18 (2003) 821-825
8. Windt M.L., Kruger T.F., Coetzee K., and Lombard C.J. Comparative analysis of pregnancy rates after the transfer of early dividing embryos versus slower dividing embryos. Hum Reprod 19 (2004) 1155-1162
9. Diedrich K., Diedrich C., Santos E., Zoll C., al-Hasani S., Reissmann T., et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 9 (1994) 788-791
10. Cheung L.P., Lam P.M., Lok I.H., Chiu T.T.Y., Yeung S.Y., Tjer C.C., et al. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial. Hum Reprod 20 (2005) 616-621
11. D'Amato G., Caroppo E., Pasquadibisceglie A., Carone D., Vitti A., and Vizziello G.M. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years. Fertil Steril 81 (2004) 1572-1577
12. Takahashi K., Mukaida T., Tomiyama T., Goto T., and Oka C. GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol. J Assist Reprod Genet 21 (2004) 317-322
13. Raga F., Casan E.M., Kruessel J., Wen Y., Bonilia-Musoles F., and Polan M.L. The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology 140 (1999) 3705-3712
14. Veeck L. Preembryo grading and degree of cytoplasmic fragmentation. In: Veeck L. (Ed). An atlas of human gametes and conceptuses: an illustrated reference for assisted reproductive technology (1999), Parthenon, New York 46-51
15. Rabinson J., Girsh E., Pinchasov M., Meltzer S., Bar-Hava I., and Tur-Kaspa I. Early cleavage of GnRH agonist versus GnRH antagonist derived embryos. Fertil Steril 80 Suppl. 3 (2003) 66
16. Schally A.V., Halmos G., and Pinski J. Terminology for luteinizing hormone-releasing hormone antagonists. Fertil Steril 64 (1995) 226
17. Pinski J., Lamharzi N., Halmos G., Groot K., Jungwirth A., Vadillo-Buenfil M., et al. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist Cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats. Endocrinology 137 (1996) 3430-3436
18. Emons G., Ortmann O., Becker M., Irmer G., Springer B., Laun R., et al. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res 53 (1993) 5439-5446
19. Emons G., Schorder B., Ortmann O., Westphalen S., Schulz K.D., and Schally A.V. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. J Clin Endocrinol Metab 77 (1993) 1458-1464
20. Minaretzis D., Jakubowski M., Mortola J.F., and Pavlou S.N. Gonadotrophin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells. J Clin Endocrinol Metab 80 (1995) 430-434
21. Ortmann O., and Diedrich K. Pituitary and extrapituitary actions of gonadotrophin-releasing hormone and its analogues. Hum Reprod 14 Suppl. 1 (1999) 194-206
22. Sharoni Y., Bosin E., Miinster A., Levy J., and Schally A.V. Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA 86 (1989) 1648-1651
23. Moretti R.M., Marelli M.M., Dondi D., Poletti A., Martini L., Motta M., et al. Luteinizing hormone releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145. J Clin Endocrinol Metab 81 (1996) 3930-3937
24. LeRoith D., Werner H., Beitner-Johnson D., and Roberts C.T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16 (1995) 143-163
25. Van Zoelen E.J.J. Polypeptide growth factors and their role in regulating the cell cycle. In: Fauser B.C.J.M., Urtherford A.J., Straus III J.F., and Van Steirteghem A. (Eds). Molecular biology in reproductive medicine (1999), Parthenon, New York 65-77
26. Liu H.C., He Z.Y., Tang Y.X., Mele C.A., Veeck L.L., Davis O., et al. Simultaneous detection of multiple gene expression in mouse and human individual preimplantation embryos. Fertil Steril 67 (1997) 733-741
27. Minaretzis D., Alper M.M., Oskowitz S.P., Lobel S.M., Mortola J.F., and Pavlou S.N. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells. Am J Obstet Gynecol 17 (1995) 1518-1525
28. Garcia-Velasco J.A., Isaza V., Vidal C., Landazabal J.R., Simon C., and Pellicer A. Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix). Hum Reprod 16 (2001) 2533-2539
29. Giampietro F., Sancilio S., Tiboni G.M., Rana R.A., and Pietro R.D. Levels of apoptosis in human granulosa cells seem to be comparable after therapy with a gonadotropin- releasing hormone agonist or antagonist. Fertil Steril 85 (2006) 412-419
30. Parborell F., Irusta G., Vitale A., Gonzalez O., Pecci A., and Tesone M. The gonadotropin-releasing hormone antagonist antide inhibits apoptosis of preovulatory follicle cells in rat ovary. Biol Reprod 72 (2005) 659-666
31. Chen C.H., Zhang X., Barnes R., Confino E., Milad M., Puscheck E., et al. Relationship between peak serum E2 levels and treatment outcome in in-vitro fertilization cycles after embryo transfer on day 3 or day 5. Fertil Steril 80 (2003) 75-79
32. Papageorgiou T., Guibert J., Goffinet F., Patrat C., Fulla Y., Janssens Y., et al. Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome. Hum Reprod 17 (2002) 2846-2850
33. Kosmas I.P., Kolibianakis E.M., and Devroey P. Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review. Hum Reprod 19 (2004) 2446-2453
34. Schoot D.C., Coelingh-Bennink H.J., Mannaerts B.M., Lamberts S.W., Bouchard P., and Fauser B.C. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotrophin deficiency. J Clin Endocrinol Metab 74 (1992) 1471-1473